Vasoactive polypeptides and cardiovascular endocrine diseases.
- Author:
Zheng-Pei ZENG
1
Author Information
1. Department of Endocrinology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China. zengzhengpei@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Cardiovascular Diseases;
physiopathology;
Endocrine System Diseases;
physiopathology;
Humans;
Intercellular Signaling Peptides and Proteins;
physiology;
Peptide Hormones;
physiology
- From:
Acta Academiae Medicinae Sinicae
2005;27(4):443-445
- CountryChina
- Language:Chinese
-
Abstract:
Cardiovascular bioactive peptides constitute life activity of human beings. They play important roles in regulating the development of cardiovascular system, and controlling disease progression. Recently, interests have arised on the adjusting effects of cardiovascular bioactive peptides on endocrine metabolism, its changes during disease course, influence on disease pathogenesis, as well as its effects on the diagnosis, treatment, and early interventions. New advances have been increasingly achieved in basic and clinical researches. It has become one of the most active areas in life sciences.
